Rosetta Genomics Ltd (NASDAQ:ROSG)

0.3745
Delayed Data
As of Apr 20
 +0.0243 / +6.94%
Today’s Change
0.23
Today|||52-Week Range
2.82
-32.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-12.9M-14.5M-17.3M-16.2M
 
 
 
 
 
Depreciation298.0K299.0K748.0K904.0K
 
 
 
 
 
Total Other Cash Flow1.2M943.0K2.5M1.4M
 
 
 
 
 
Funds From Operations-11.4M-13.3M-14.1M-13.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-795.0K318.0K2.8M-3.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-10.6M-13.6M-16.9M-10.4M
 
 
 
 
 
 
InvestingIncrease In Investments-7.5M----0.00
 
 
Decrease In Investments0.0017.0K--0.00
 
 
Capital Expenditures-626.0K-247.0K-273.0K-223.0K
 
 
 
 
 
Net Assets From Acquisitions -----2.1M0.00
 
 
Other Investing - Uses0.00-28.0K0.000.00
 
 
Other Investing - Sources10.0K0.006.5M1.0M
 
 
 
 
Net Cash Flow Investing-8.2M-258.0K4.1M823.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.00-28.0K
 
 
Net Proceeds Stock Sale4.7M5.0M17.3M3.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing4.7M5.0M17.3M3.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-14.0M-8.8M4.5M-6.3M